HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ekkehard Dikomey Selected Research

Genomic Instability

5/2013RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma.
3/2012DNA damage by X-rays and their impact on replication processes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ekkehard Dikomey Research Topics

Disease

20Neoplasms (Cancer)
06/2023 - 07/2006
13Squamous Cell Carcinoma of Head and Neck
06/2022 - 03/2013
4Head and Neck Neoplasms (Head and Neck Cancer)
06/2022 - 08/2002
4Fibrosis (Cirrhosis)
01/2015 - 08/2002
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 11/2016
3Breast Neoplasms (Breast Cancer)
04/2012 - 11/2003
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2018 - 10/2011
2Glioblastoma (Glioblastoma Multiforme)
09/2016 - 10/2015
2Erythema
01/2015 - 04/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013 - 01/2013
2Genomic Instability
05/2013 - 03/2012
2Ataxia Telangiectasia (Louis Bar Syndrome)
09/2012 - 08/2002
2Chromosome Aberrations (Chromosome Abnormalities)
03/2009 - 08/2002
1Necrosis
06/2023
1Anaplastic Thyroid Carcinoma
06/2023
1Aneuploidy (Aneuploid)
11/2019
1Infections
06/2018
1Ovarian Neoplasms (Ovarian Cancer)
11/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Adenocarcinoma
05/2013
1Hypersensitivity (Allergy)
01/2013
1Disease Progression
01/2011
1Blast Crisis (Blast Phase)
01/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2011
1Nijmegen Breakage Syndrome
08/2002
1Xerostomia
08/2002
1Telangiectasis (Telangiectasia)
08/2002
1Mucositis
08/2002

Drug/Important Bio-Agent (IBA)

91,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2022 - 03/2009
7ErbB Receptors (EGF Receptor)IBA
10/2015 - 07/2006
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2011
4Proteins (Proteins, Gene)FDA Link
09/2015 - 07/2011
3Sorafenib (BAY 43-9006)FDA Link
09/2016 - 11/2013
2Cisplatin (Platino)FDA LinkGeneric
06/2022 - 04/2016
2dactolisibIBA
06/2022 - 02/2020
2CarbonIBA
01/2022 - 10/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018 - 11/2016
2Cetuximab (Erbitux)FDA Link
12/2014 - 03/2013
2Codon (Codons)IBA
04/2012 - 10/2010
2Carisoprodol (Soma)FDA LinkGeneric
10/2010 - 11/2003
1Monoclonal AntibodiesIBA
06/2023
1atezolizumabIBA
06/2023
1LigandsIBA
06/2023
1PhosphatidylserinesIBA
06/2023
1Indicators and Reagents (Reagents)IBA
01/2022
1Proteasome InhibitorsIBA
03/2019
1Bortezomib (Velcade)FDA Link
03/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2019
1CREB-Binding ProteinIBA
06/2018
1LipopolysaccharidesIBA
06/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2017
1RoscovitineIBA
12/2017
1Biomarkers (Surrogate Marker)IBA
02/2017
1DNA HelicasesIBA
11/2016
1epidermal growth factor receptor VIIIIBA
10/2015
1Gefitinib (Iressa)FDA Link
10/2015
1IsotopesIBA
09/2015
1Amino AcidsFDA Link
09/2015
1olaparibIBA
12/2014
1Calcibiotic Root Canal SealerIBA
05/2013
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2013
1MicroRNAs (MicroRNA)IBA
01/2013
1EndonucleasesIBA
09/2012
1Phosphotransferases (Kinase)IBA
09/2012
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2011
1BIBR 1532IBA
01/2011
1ORALIT (ORS)IBA
10/2010
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2006
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2006
1DNA Ligase ATPIBA
08/2002

Therapy/Procedure

14Radiotherapy
06/2023 - 08/2002
11Therapeutics
06/2018 - 08/2002
3Chemoradiotherapy
06/2022 - 09/2013
1Immunotherapy
06/2023
1Prostatectomy (Retropubic Prostatectomy)
01/2018
1Segmental Mastectomy (Lumpectomy)
01/2015
1Drug Therapy (Chemotherapy)
12/2014
1Radioimmunotherapy
03/2013